• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Ethicon Inc. STRATAFIX; Suture, absorbable, synthetic, polyglycolic acid

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Ethicon Inc. STRATAFIX; Suture, absorbable, synthetic, polyglycolic acid Back to Search Results
Catalog Number SXMP1B427
Medical Device Problem Codes Break (1069); Material Separation (1562)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 07/23/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that during laparoscopic endometriosis surgery on (b)(6) 2026 and a barbed suture was used.During the procedure, after the suture needle passed through the tissue and when suturing the endometrium, pulling off suture needle happened upon suture lifting and the needle fell into the abdominal cavity of the patient.It took more than 1 hour to find the needle in patient¿s abdominal cavity, and the surgical incision on the abdominal wall of the patient was enlarged.The patient was in normal condition currently.Additional information was requested.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.What is the surgeon¿s experience with this stratafix suture? please provide the patient's demographic information including age, gender, weight, bmi at the time of index procedure.The diagnosis and indication for the index surgical procedure? were any concomitant procedures performed? what was the initial approach for the index surgical procedure? (open, laparoscopic or other)? on what tissue was the suture used? what was the tissue condition (normal, thin, calcified, fragile, diseased)? for the original intended closure, how were all layers closed? was the fixation loop secured to tissue at the initiation of suture use during the index procedure? was at least one reverse stitch performed prior to closure? what instruments were used to grasp the needle? where was the needle grasped during use? please describe any medical/surgical intervention required for this suture event including dates and results.What tissue was enlarged and by how much was the incision enlarged to remove the needle? please specify was additional dissection required in other tissues other than the target tissue? if yes, please describe.Did the operating surgeon observe any suture deficiency or anomaly before, during, after the suture placement or during any re-operation? other relevant patient history/concomitant medications? what is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient's current status? surgeon¿s name?.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATAFIX
Common Device Name
Suture, absorbable, synthetic, polyglycolic acid
Manufacturer (Section D)
Ethicon Inc.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
Ethicon Inc.-San Lorenzo PR
road 183, km 8.3
san lorenzo PR 00754
PR   00754
Manufacturer Contact
orla o'mahony
1000 route 202
raritan, NJ 08869
+1(303)552-6892
MDR Report Key50160128
Report Number2210968-2026-07887
Device Sequence Number15788120
Product Code GAM
UDI-Device Identifier10705031236516
UDI-Public(01)10705031236516(17)270831(10)10B31M
Combination Product (Y/N)Y
Initial Reporter CountryUS
PMA/510(K) Number
K182873
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/29/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberSXMP1B427
Device Lot Number10B31M
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer09/10/2026
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/24/2026
Supplement Date Received by Manufacturer08/13/2026
09/10/2026
Initial Report FDA Received Date08/06/2026
Supplement Report FDA Received Date09/02/2026
09/29/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/20/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-